logo/base Created with Sketch.
logo echosens
en
chevron Contact
English version chevron
Change region

Clinical e-news

The newsletter designed to keep the FibroScan® community up-to-date on clinical news and resources.

wave

The following articles are the latest clinical peer-reviewed publications on liver health management.

SSM@100Hz by FibroScan® Improves the Non-Invasive Diagnosis of CSPH, Supporting its Implementation into Clinical Practice chevron

In this European multicenter study of patients with cACLD, predominantly due to metabolic diseases, SSM by VCTE™ at 100 Hz significantly improved non-invasive diagnosis of CSPH compared to standard methods. The comprehensive model (NICER) incorporating SSM, LSM, platelet count, and BMI establishes a new standard for CSPH risk stratification, enhancing access to disease-modifying treatments for these patients.

> More information 

 

Application of FIB-4 + LSM by VCTE™ with FibroScan® has Excellent Diagnostic Performance in Screening for Advanced Fibrosis in Diabetology Settings chevron

The FIB-4 score / VCTE™ algorithm showed excellent diagnostic performance, demonstrating its applicability for routine screening in diabetology.

  • Effective Screening: A two-step strategy (FIB-4 score followed by VCTE™) effectively identifies patients at high risk of advanced fibrosis.
  • Noninvasive Test Performance: FIB-4 outperformed NFS and MAF-5, with a high negative predictive value (97.2%) for ruling out advanced fibrosis.
  • Referral to Specialized Care: The FIB-4/VCTE™ strategy led to appropriate referrals for hepatology care, though 2% of referrals were false positives.
  • Practical for Clinics: The two-step approach is practical and effective for identifying high-risk patients in diabetology and nutrition clinics.

 

> More information